Grimm, MO;Machiels, JP;Wülfing, C;Richel, D;Treiber, U;de Groot, M;Beuzeboc, P;Farrell, J;Colman, J;El-Hariry, I.A single arm, multicentre, open-label phase II study of orally administered lapatinib (GW572016) as single-agent, second-line treatment of patients with locally advanced or metastatic transitional cell carcinoma.Ann Oncol.2005.16 Suppl..41-41

Wülfing, C;Machiels, JP;Richel, D;Grimm, MO;Treiber, U;de Groot, M;Beuzeboc, P;Farrell, J;Stone, NL;Leopold, L;El-Hariry, I.A single arm, multicenter, open label, phase II study of lapatinib as 2L treatment of pts with locally advanced/metastatic transitional cell carcinoma (TCC) of the urothelial tract.J Clin Oncol.2005.23.16.401S-401S

Elhilali, M;Vallancien, G;van Moorselaar, J;Harving, N;Hartung, R;Emberton, M;Alcaraz, A;Matzkin, H.Beneficial effects of alfuzosin 10mg OD on LUTS, quality of life and sexual function: A 2-year experience in BPH patients in real life practice.J Urol.2005.173 Suppl..4.463-463

Treiber, U;Bossner, P;Kubler, H;van Randenborgh, H;Paul, R;Piert, M;Schwaiger, M;Hartung, R.Diagnostic efficiency of 11C-choline PET in patients with bladder cancer scheduled for radical cystectomy.J Urol.2005.173 Suppl..4.373-373

Emberton, M;Elhilali, M;Hartung, R;Alcaraz, A;Harving, N;Matzkin, H;van Moorselaar, J.Response or not to alfuzosin treatment is predictive of AUR and BPH surgery.J Urol.2005.173 Suppl..4.463-463

van Moorselaar, J;Harving, N;Matkin, H;Emberton, M;Hartung, R;Alcaraz, A;Elhilali, M;Vallancien, G.Improvement of sexual function with alfuzosin 10mg once daily is related to baseline LUTs and bother severity.J Urol.2005.173 Suppl..4.461-461

Alschibaja, M;Mueller, C;Massmann, J;Funk, A;van Randenborgh, H;Hartung, R;Paul, R.Definition of risk groups for PSA failure after radical prostatectomy - Tumour volume or multivariate analysis?.J Urol.2005.173 Suppl..4.281-281

Retz, MM;Sidhu, SS;Blaveri, E;Kerr, SC;Dolganov, GM;Lehmann, J;Carroll, P;Simko, J;Waldman, FM;Basbaum, C.CXCR4 expression reflects tumor progression and regulates motility of bladder cancer cells..Int J Cancer.2005.114.2.182-9

Retz, M;Sidhu, SS;Lehmann, J;Tamamura, H;Fujii, N;Basbaum, C.New HIV-drug inhibits in vitro bladder cancer migration and invasion..Eur Urol.2005.48.6.1025-30

Lehmann, J;Retz, M;Wiemers, C;Beck, J;Thüroff, J;Weining, C;Albers, P;Frohneberg, D;Becker, T;Funke, PJ;Walz, P;Langbein, S;Reiher, F;Schiller, M;Miller, K;Roth, S;Kalble, T;Sternberg, D;Wellek, S;Stöckle, M.Adjuvant cisplatin plus methotrexate versus methotrexate, vinblastine, epirubicin, and cisplatin in locally advanced bladder cancer: results of a randomized, multicenter, phase III trial (AUO-AB 05/95)..J Clin Oncol.2005.23.22.4963-74